News Follow-Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center

2022/02/09

New Year's condolences warm people's hearts | Secretary Hu Xiaojun of the Party Committee of Shenzhen Bay Laboratory Visits Pingshan Center for New Year's condolences

2022/01/24

2022 Spring Tea party~

From the 2022 Spring Tea party to the Spring Festival after New Year's Day, Pingshan Center held the Spring Tea party on January 14.

2022/01/12

A new non-invasive addiction treatment device project, with Pingshan Center charging the work of drug and addiction rehabilitation

On January 5th, the Pingshan Biopharmaceutical R&D and Transformation Center of Shenzhen Bay Laboratory (hereinafter referred to as "Pingshan Center") collaborated with Xiaolong Shensi (Xiamen) Technology Development Co., Ltd. (hereinafter referred to as "Xiaolong Shensi") to establish the NeuroSee-Pingshan Center non-invasive addiction treatment device project.

2022/01/07

Research Trends | Pingshan Center Achieves Important Research Progress in Developing Novel Peptide Inhibitors for Deubiquitinase USP30

On the same day, the Li Zigang/Yin Feng research group at Pingshan Center collaborated with Xu Naihan from Tsinghua International Graduate School to publish a research paper titled "Identification of an automobile, mitophagy inducing peptide derived from the transmembrane domain of USP30" in the internationally renowned journal "Autophagy" (IF=16.016)

2022/01/05

Scientific Research Trends | Pingshan Center has made research progress in the development of peptide conjugated drugs (PDCs) against COVID-19

Recently, Li Zigang/Yin Feng of Pingshan Center and Zhou Yaoqi of Shenzhen Bay Laboratory jointly developed a new type of polypeptide drug conjugates (PDCs) targeting COVID-19 (SARS-CoV-2) Papain like protease (PLpro) protein, and their achievements were published in the Journal of Medical Chemistry, a journal of Medicinal chemistry

2021/12/31

Scientific Research Trends | Pingshan Center Developing New Methods for Amination Promotion of Sulfate Salts in Aqueous Phase

Li Zigang, the research group of Chemical biology and Biotechnology of Peking University Shenzhen Graduate School and Pingshan Biomedical R&D and Transformation Center of Shenzhen Bay Laboratory, published a paper entitled "Electronic Sulfonium Promoted Peptide and Protein Enhancement in Aqueous Media" on the magazine Organic Letters.

2021/12/29

Exchange Visit | Director Li Zigang Led a Team to Visit Guangdong Provincial Small Molecular New Drug Innovation Center

On the afternoon of December 27th, Li Zigang, Executive Director of Pingshan Biomedical Research and Transformation Center (hereinafter referred to as "Pingshan Center") at Shenzhen Bay Laboratory, was invited to visit Guangdong Small Molecule New Drug Innovation Center | Shenzhen Small Molecule New Drug Innovation Center Co., Ltd. (hereinafter referred to as "Innovation Center"). Senior executives such as He Xun, General Manager of the Innovation Center, Jin Feng, R&D Director, and Li Zhenwei, Project Director warmly received and held a symposium.

2021/12/20

Pengcheng Laboratory Visits Pingshan Center to Promote Exchange

On December 15, 2021, Chen Jie, the person in charge of the Shennong Platform at Pengcheng Laboratory, and his delegation visited the Pingshan Pharmaceutical Research and Development Transformation Center at Shenzhen Bay Laboratory for exchange and visit.

2021/12/13

Innovation driven development, technology leading the future! The final of the 2021 Beihang Global Science and Technology Innovation Competition Guangdong–Hong Kong–Macao Greater Bay Area will be held in Pingshan

On December 11, 2021, the final of the 5th Beihang Global Science and Technology Innovation Competition Guangdong–Hong Kong–Macao Greater Bay Area was held in Pingshan. The final of the Beihang Global Science and Technology Innovation Competition Guangdong–Hong Kong–Macao Greater Bay Area has been held in Pingshan, Shenzhen for four consecutive times, covering many fields such as artificial intelligence, medical equipment, medical detection, and unmanned driving. As a special witness, Chuangshai has witnessed the high-quality and high-speed development process of "Innovation Pingshan, Future City".